Chang Bong Jun

Title: Chang Bong Jun - Innovator in Human Growth Hormone Purification

Introduction

Chang Bong Jun is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of methods for purifying long-acting human growth hormones. His innovative work has the potential to impact medical treatments and therapies.

Latest Patents

Chang Bong Jun holds a patent for a method of purifying a long-acting human growth hormone. The patent describes a specific isoform of the long-acting human growth hormone, known as NexP-hGH protein, which is produced by fusing human growth hormone with a highly glycosylated alpha-1 antitrypsin mutant. This fusion enhances the long-acting properties of the hormone in vivo. The purification method involves several steps, including anion-exchange resin chromatography, hydrophobic resin chromatography, and affinity chromatography, ensuring high purity of the NexP-hGH protein.

Career Highlights

Throughout his career, Chang Bong Jun has worked with prominent companies in the biotechnology sector. He has been associated with Cj Healthcare Corporation and Alteogen, Inc., where he has contributed to advancements in pharmaceutical technologies. His expertise in protein purification and hormone development has established him as a key figure in his field.

Collaborations

Chang Bong Jun has collaborated with notable professionals in the industry, including Gil Bu Kang and Chung Min Lee. These collaborations have further enhanced his research and development efforts, leading to innovative solutions in biotechnology.

Conclusion

Chang Bong Jun's work in the purification of long-acting human growth hormones exemplifies the importance of innovation in biotechnology. His contributions are paving the way for advancements in medical treatments and therapies.